Tuesday 14th November 2017
|Text too small?|
Pharmac has promoted operations director Sarah Fitt to the top job after chief executive Steffan Crausaz announced his exit for the private sector starting next year.
Fitt will take over the reins on Jan. 6, replacing Crausaz who is taking up a new role in the private sector after heading up the government drug-buying agency for more than six years and having worked at Pharmac for more than 14 years. Crausaz led the extension of Pharmac's scope into hospital medicines, vaccines, and medical devices, the agency said.
"When Pharmac does its job well more patients are able to benefit from medicines and health services that otherwise would not be available to them. It has been a privilege to have been given the opportunity to contribute to this goal," said Crausaz.
Fitt has more than five years executive experience at Pharmac and brings a wealth of clinical and management experience to her role, said Pharmac chair Stuart McLauchlan.
“Sarah is one of the most outstanding clinical leaders in New Zealand. Her experience is going to be vital for the continuity of Pharmac and we wanted to ensure that we retained that talent," he said.
The news comes as the Trade and Export Growth Minister David Parker said the revamped Comprehensive and Progressive Agreement for the Trans-Pacific Partnership includes greater protection for Pharmac.
"The Pharmac model continues to be protected. Further improvements now achieved include suspension of patent extensions which could have increased the cost of medicine to the government," Parker said in a statement.
One of Labour's campaign promises was to fund Pharmac to get New Zealanders "the latest medicines quicker," arguing that the state agency had been underfunded under the previous government.
No comments yet
MARKET CLOSE: NZ shares gain as Trade Me hits record on takeover
NZ dollar higher against USD as jitters about China-US trade tensions recede
Rakon boosts bank funding to meet increased telco demand
Underfunded Overseer farm management tool needs thorough review: Upton
Motor vehicle lending helps UDC lift annual profit 6%
Orr says RBNZ still under-resourced, funding model part of second phase of review
Leading business brokerage firm LINK raises a further NZ$3.45m in capital
Travel insurance and the AirNZ strike
Industrial heat a challenge for cost-effective emissions reduction
Hallenstein Glasson wary of margin squeeze in second half